Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™.
The Cymerus™ technology has several characteristics which makes it ideal for the development of cell-based therapeutics. Most critically, the Cymerus™ manufacturing process ensures that cells for therapeutic use can be produced in virtually limitless quantities. This means that Cynata will not have to constantly seek out fresh stem cell donors to fuel its manufacturing demands. This has the potential to create a new standard in the emergent arena of regenerative medicine and stem cell therapeutics and provides Cynata with both a unique differentiator and an important competitive position.
Like many biotechnology firms in the sector, Cynata were relying on a cloud base file management system, to manage product and trial documentation that it receives from many sources. Cynata approached SeerPharma to review the data security, data integrity and auditability of this file sharing service, and provide a recommendation on a secure, simple, cost effective solution to assist. SeerPharma also developed validation documentation to support the final solution.
“SeerPharma were able to quickly understand our needs as a small company operating a virtual business model, and tailor their advice accordingly. We were happy with what they delivered and would recommend them to other start up biotechnology firms looking for greater Quality Assurance/Security with their data management.”
- Kilian Kelly, VP Product Development , Cynata
Contact us for support if you’re a small biotech / medtech company managing multiple streams of data, and require assistance with ensuring your data can be managed in a secure environment.
This post comes from our April 2016 Journal.